# A Phase I Clinical Trial of DARC

> **NCT02394613** · PHASE1 · UNKNOWN · sponsor: **University College, London** · enrollment: 16 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension
- Glaucoma, Suspect

## Interventions

- **DRUG:** ANX776

## Key facts

- **NCT ID:** NCT02394613
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2015-11
- **Final completion:** 2016-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02394613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02394613, "A Phase I Clinical Trial of DARC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02394613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*